selected publications
-
academic article
-
A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patients.
British Journal Of Nutrition.
119.
2018
A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults.
Nature Communications.
9.
2018
Acute Effects of Dietary Carbohydrate Restriction on Glycemia, Lipemia and Appetite Regulating Hormones in Normal-Weight to Obese Subjects.
Nutrients.
10.
2018
Acute administration of interleukin‐6 does not increase secretion of glucagon‐like peptide‐1 in mice.
Physiological Reports.
6.
2018
Adaptive changes in pancreas post Roux‐en‐Y gastric bypass induced weight loss.
Diabetes/Metabolism Research and Reviews.
34.
2018
Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.
Molecular Metabolism.
11.
2018
Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs.
Scandinavian Journal of Gastroenterology.
53.
2018
Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
BMC Genetics.
19.
2018
Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetes.
Nutrition & Diabetes.
8.
2018
Comparison of Glycomacropeptide with Phenylalanine Free-Synthetic Amino Acids in Test Meals to PKU Patients: No Significant Differences in Biomarkers, Including Plasma Phe Levels.
Journal of Nutrition and Metabolism.
2018.
2018
Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects.
Metabolic Syndrome and Related Disorders.
16.
2018
Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.
AJP Endocrinology and Metabolism.
314.
2018
Do we know the true mechanism of action of the DPP‐4 inhibitors?.
Diabetes Obesity and Metabolism.
20.
2018
Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial.
Diabetes Obesity and Metabolism.
20.
2018
Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.
Diabetes Care.
41.
2018
Effects of Smoking Versus Nonsmoking on Postprandial Glucose Metabolism in Heavy Smokers Compared With Nonsmokers.
Diabetes Care.
41.
2018
Effects of a diet rich in arabinoxylan and resistant starch compared with a diet rich in refined carbohydrates on postprandial metabolism and features of the metabolic syndrome.
European Journal of Nutrition.
57.
2018
Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice.
PLoS ONE.
13.
2018
Enteroendocrine K and L cells in healthy and type 2 diabetic individuals.
Diabetologia.
61.
2018
Erratum to semaglutide seems to be more effective the other GLP-1Ras..
Annals of Translational Medicine.
6.
2018
Erratum: Effect of GLP‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: A randomized, placebo‐controlled trial.
Diabetes Obesity and Metabolism.
20.
2018
Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.
Diabetologia.
61.
2018
GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study.
Diabetologia.
61.
2018
Ghrelin secretion in humans – a role for the vagus nerve?.
Neurogastroenterology & Motility.
30.
2018
Glucagon-Like Peptide-1 Inhibits Prandial Gastrointestinal Motility Through Myenteric Neuronal Mechanisms in Humans..
The Journal of Clinical Endocrinology & Metabolism.
103.
2018
Glucose Tolerance Tests and Osteocalcin Responses in Healthy People.
Frontiers in Endocrinology.
9.
2018
Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia..
The Journal of Clinical Endocrinology & Metabolism.
103.
2018
Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
Peptides.
100.
2018
Glucose‐lowering effects and mechanisms of the bile acid‐sequestering resin sevelamer.
Diabetes Obesity and Metabolism.
20.
2018
Gut: A key player in the pathogenesis of type 2 diabetes?.
Critical Reviews in Food Science and Nutrition.
58.
2018
Hemodynamic Effects of Glucagon: A Literature Review.
The Journal of Clinical Endocrinology & Metabolism.
103.
2018
Hepatic Insulin Clearance in Regulation of Systemic Insulin Concentrations—Role of Carbohydrate and Energy Availability.
Diabetes.
67.
2018
Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.
AJP Gastrointestinal and Liver Physiology.
314.
2018
Hyperosmolar Duodenal Saline Infusion Lowers Circulating Ghrelin and Stimulates Intestinal Hormone Release in Young Men.
The Journal of Clinical Endocrinology & Metabolism.
103.
2018
Impact of weight loss achieved through a multidisciplinary intervention on appetite in patients with severe obesity.
AJP Endocrinology and Metabolism.
315.
2018
Incretin responses to oral glucose and mixed meal tests and changes in fasting glucose levels during 7 years of follow-up: The Hoorn Meal Study.
PLoS ONE.
13.
2018
Inhibiting RHOA Signaling in Mice Increases Glucose Tolerance and Numbers of Enteroendocrine and Other Secretory Cells in the Intestine.
Gastroenterology.
155.
2018
Insulin Secretion Depends on Intra-islet Glucagon Signaling.
Cell Reports.
25.
2018
Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control.
Cell Metabolism.
27.
2018
Is glucagon‐like peptide‐1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?.
Diabetes Obesity and Metabolism.
20.
2018
Mechanisms in Bariatric Surgery: Gut Hormones, Diabetes Resolution and Weight loss.
Surgery for Obesity and Related Diseases.
14.
2018
Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.
JCI Insight.
3.
2018
Morning and afternoon appetite and gut hormone responses to meal and stress challenges in obese individuals with and without binge eating disorder.
International Journal of Obesity.
42.
2018
No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course.
BMC Endocrine Disorders.
18.
2018
Non-insulin pharmacological therapies for treating type 1 diabetes.
Expert Opinion on Pharmacotherapy.
19.
2018
Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
The Journal of Clinical Endocrinology & Metabolism.
103.
2018
Oxyntomodulin: Actions and role in diabetes.
Peptides.
100.
2018
Patient profiling for success after weight loss surgery (GO Bypass study): An interdisciplinary study protocol.
Contemporary Clinical Trials Communications.
10.
2018
Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist.
Cell Metabolism.
28.
2018
Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery.
Cell Systems.
7.
2018
Pre-Meal Effect of Whey Proteins on Metabolic Parameters in Subjects with and without Type 2 Diabetes: A Randomized, Crossover Trial.
Nutrients.
10.
2018
Reduced GLP-1 Secretion at 30 Minutes After a 75g Oral Glucose Load is Observed in Gestational Diabetes Mellitus: A Prospective Cohort Study.
Diabetes.
67.
2018
Relationship between Optimum Mini‐doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes – A Simulation Study.
Basic & Clinical Pharmacology & Toxicology.
122.
2018
Renoprotective effects of dulaglutide in patients with T2DM and CKD.
Nature Reviews Nephrology.
14.
2018
Response to Letter to the Editor: “Hemodynamic Effects of Glucagon: A Literature Review”.
The Journal of Clinical Endocrinology & Metabolism.
103.
2018
Restoration of enteroendocrine and pancreatic function after internal hernia and short bowel syndrome in a young woman with gastric bypass – a 2‐year follow‐up.
Physiological Reports.
6.
2018
SaO009GASTROINTESTINAL MOTILITY IN PATIENTS WITH END-STAGE RENAL DISEASE ON CHRONIC HEMODIALYSIS.
Nephrology,Dialysis and Transplantation.
33.
2018
Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery.
EBioMedicine.
28.
2018
The Glucagon Like Peptide-2 ‘Axis’: Capacity for Production and Response Following Intestinal Resection or Repair of Gastroschisis in Infants.
Journal of Pediatric Surgery.
53.
2018
The Prebiotic Inulin Improves Substrate Metabolism and Promotes Short-Chain Fatty Acid Production in Overweight to Obese Men.
Metabolism.
87.
2018
The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial.
Lipids in Health and Disease.
17.
2018
The bile acid‐sequestering resin sevelamer eliminates the acute GLP‐1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes.
Diabetes Obesity and Metabolism.
20.
2018
The effect of casein, hydrolyzed casein, and whey proteins on urinary and postprandial plasma metabolites in overweight and moderately obese human subjects.
Journal of the Science of Food and Agriculture.
98.
2018
The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon.
AJP Gastrointestinal and Liver Physiology.
315.
2018
37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3).
Critical Care.
21.
2017
A safety and pharmacokinetic dosing study of glucagon-like peptide 2 in infants with intestinal failure.
Journal of Pediatric Surgery.
52.
2017
A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite.
AJP Endocrinology and Metabolism.
313.
2017
Acute effects of glucagon‐like peptide‐1, GLP‐19–36 amide, and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers.
Physiological Reports.
5.
2017
Addition of Rye Bran and Pea Fiber to Pork Meatballs Enhances Subjective Satiety in Healthy Men, but Does Not Change Glycemic or Hormonal Responses: A Randomized Crossover Meal Test Study..
Journal of Nutrition.
147.
2017
Addition of a dipeptidyl peptidase‐4 inhibitor, sitagliptin, to ongoing therapy with the glucagon‐like peptide‐1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes.
Diabetes Obesity and Metabolism.
19.
2017
Chenodeoxycholic acid stimulates glucagon‐like peptide‐1 secretion in patients after Roux‐en‐Y gastric bypass.
Physiological Reports.
5.
2017
Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production.
Cell Reports.
21.
2017
Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial.
Scientific Reports.
7.
2017
Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
Diabetologia.
60.
2017
Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.
Journal of Diabetes Science and Technology.
11.
2017
DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity.
PLoS ONE.
12.
2017
Defects in α-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals.
Diabetes Care.
40.
2017
Difference in postprandial GLP-1 response despite similar glucose kinetics after consumption of wheat breads with different particle size in healthy men.
European Journal of Nutrition.
56.
2017
Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects.
Bone.
97.
2017
Discovery, characterization, and clinical development of the glucagon-like peptides.
Journal of Clinical Investigation.
127.
2017
Effect of GLP‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: a randomized, placebo‐controlled trial.
Diabetes Obesity and Metabolism.
19.
2017
Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.
JAMA Psychiatry.
74.
2017
Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome.
Endocrine Connections.
6.
2017
Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats.
PLoS ONE.
12.
2017
Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues.
Diabetes Care.
40.
2017
Erratum to: Vagal Blocking for Obesity Control: a Possible Mechanism-Of-Action.
Obesity Surgery.
27.
2017
Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
NMCD - Nutrition,Metabolism and Cardiovascular Diseases.
27.
2017
GIP(3–30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release.
Biochemical Pharmacology.
131.
2017
Genetic determinants of circulating GIP and GLP-1 concentrations.
JCI Insight.
2.
2017
Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver–α-Cell Axis.
Diabetes.
66.
2017
Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes.
Trends in Endocrinology and Metabolism.
28.
2017
Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors.
Physiological Reports.
5.
2017
Glucagon‐like peptide‐1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men.
Physiological Reports.
5.
2017
Glucose ingestion causes cardiac repolarization disturbances in type 1 long QT syndrome patients and healthy subjects.
Heart Rhythm.
14.
2017
Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response.
AJP Endocrinology and Metabolism.
312.
2017
Glycaemic control and weight loss with semaglutide in type 2 diabetes.
The Lancet Diabetes & Endocrinology.
5.
2017
Health care professionals from developing countries report educational benefits after an online diabetes course.
BMC Medical Education.
17.
2017
High-Intensity Interval Training, Appetite, and Reward Value of Food in the Obese.
Medicine & Science in Sports & Exercise.
49.
2017
Hypoglycemia-Associated EEG Changes Following Antecedent Hypoglycemia in Type 1 Diabetes Mellitus.
Diabetes Technology & Therapeutics.
19.
2017
Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
NMCD - Nutrition,Metabolism and Cardiovascular Diseases.
27.
2017
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.
Cell Metabolism.
26.
2017
Increased glucose‐stimulated FGF21 response to oral glucose in obese nondiabetic subjects after Roux‐en‐Y gastric bypass.
Clinical Endocrinology.
86.
2017
Instrumentalization of Eating Improves Weight Loss Maintenance in Obesity.
Obesity Facts.
10.
2017
Insulin and Glucagon: Partners for Life..
Endocrinology.
158.
2017
Interdependency of EGF and GLP-2 Signaling in Attenuating Mucosal Atrophy in a Mouse Model of Parenteral Nutrition.
Cellular and Molecular Gastroenterology and Hepatology.
3.
2017
Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo‐controlled, double‐blind, parallel‐group study.
Diabetes Obesity and Metabolism.
19.
2017
Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study.
Diabetes Care.
40.
2017
MO019INCRETIN EFFECT IS REDUCED IN END-STAGE RENAL DISEASE.
Nephrology,Dialysis and Transplantation.
32.
2017
Mathematical Modelling of Glucose‐Dependent Insulinotropic Polypeptide and Glucagon‐like Peptide‐1 following Ingestion of Glucose.
Basic & Clinical Pharmacology & Toxicology.
121.
2017
Near‐normalization of glycaemic control with glucagon‐like peptide‐1 receptor agonist treatment combined with exercise in patients with type 2 diabetes.
Diabetes Obesity and Metabolism.
19.
2017
Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference.
Diabetes Care.
40.
2017
Nutrient re‐routing and altered gut‐islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux‐en‐Y gastric bypass.
Diabetic Medicine.
34.
2017
On the relationship between glucose absorption and glucose‐stimulated secretion of GLP‐1, neurotensin, and PYY from different intestinal segments in the rat.
Physiological Reports.
5.
2017
Pancreatic Polypeptide in Parkinson’s Disease: A Potential Marker of Parasympathetic Denervation.
Journal of Parkinson's Disease.
Preprint.
2017
Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia.
Circulation.
135.
2017
Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus.
BMJ Open Diabetes Research & Care.
5.
2017
Role of Glucagon in Catabolism and Muscle Wasting of Critical Illness and Modulation by Nutrition.
American Journal of Respiratory and Critical Care Medicine.
196.
2017
Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.
European Journal of Endocrinology.
177.
2017
Safety and Dosing Study of Glucagon‐Like Peptide 2 in Children With Intestinal Failure.
Journal of Parenteral and Enteral Nutrition.
41.
2017
Semaglutide seems to be more effective the other GLP-1Ras..
Annals of Translational Medicine.
5.
2017
Short communication: Promotion of glucagon-like peptide-2 secretion in dairy calves with a bioactive extract from Olea europaea.
Journal of Dairy Science.
100.
2017
Short‐term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open‐label crossover trial.
Diabetes Obesity and Metabolism.
19.
2017
Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes..
The Journal of Clinical Endocrinology & Metabolism.
102.
2017
Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals.
Gastroenterology.
153.
2017
Sweet Taste Receptor Activation in the Gut Is of Limited Importance for Glucose-Stimulated GLP-1 and GIP Secretion.
Nutrients.
9.
2017
TRPV1: A Potential Therapeutic Target in Type 2 Diabetes and Comorbidities?.
Trends in Molecular Medicine.
23.
2017
The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers..
The Journal of Clinical Endocrinology & Metabolism.
102.
2017
The Gluco- and Liporegulatory and the Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) are Abolished By an Antagonist of the Human GIP Receptor.
Diabetes.
66.
2017
The Gut: A Key to the Pathogenesis of Type 2 Diabetes?.
Metabolic Syndrome and Related Disorders.
15.
2017
The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes.
Diabetes Obesity and Metabolism.
19.
2017
The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice.
Diabetologia.
60.
2017
Vagal Blocking for Obesity Control: a Possible Mechanism-Of-Action.
Obesity Surgery.
27.
2017
Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypass.
AJP Regulatory Integrative and Comparative Physiology.
312.
2017
Why is it so difficult to measure glucagon-like peptide-1 in a mouse?.
Diabetologia.
60.
2017
Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect.
Diabetologia.
60.
2017
A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats.
PLoS ONE.
11.
2016
Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes.
Diabetologia.
59.
2016
Atrial Natriuretic Peptide in the High Normal Range Is Associated With Lower Prevalence of Insulin Resistance.
The Journal of Clinical Endocrinology & Metabolism.
101.
2016
COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES.
Endocrine Practice.
22.
2016
Cephalic phase secretion of insulin and other enteropancreatic hormones in humans.
AJP Gastrointestinal and Liver Physiology.
310.
2016
Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses.
The Journal of Clinical Endocrinology & Metabolism.
101.
2016
Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.
Journal of Internal Medicine.
279.
2016
Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men..
Clinical Science.
130.
2016
Disturbed postprandial glucose metabolism and gut hormone responses in non‐diabetic patients with psoriasis.
British Journal of Dermatology.
175.
2016
Do glucagonomas always produce glucagon?.
Bosnian Journal of Basic Medical Sciences.
15.
2016
Do glucagonomas always produce glucagon?.
Bosnian Journal of Basic Medical Sciences.
16.
2016
Dynamics of glucagon secretion in mice and rats revealed using a validated sandwich ELISA for small sample volumes.
AJP Endocrinology and Metabolism.
311.
2016
Effect of Liraglutide Treatment on Jejunostomy Output in Patients With Short Bowel Syndrome: An Open‐Label Pilot Study.
Journal of Parenteral and Enteral Nutrition.
42.
2016
Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon‐like peptide‐1 secretion.
Diabetes Obesity and Metabolism.
18.
2016
Effects of Gastric Bypass and Gastric Banding on Bone Remodeling in Obese Patients With Type 2 Diabetes.
The Journal of Clinical Endocrinology & Metabolism.
101.
2016
Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial.
Cell Metabolism.
24.
2016
Effects of Peripheral Neurotensin on Appetite Regulation and Its Role in Gastric Bypass Surgery..
Endocrinology.
157.
2016
Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial.
International Journal of Obesity.
40.
2016
Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
AJP Endocrinology and Metabolism.
310.
2016
Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease.
Journal of Hepatology.
64.
2016
Effects of subcutaneous, low‐dose glucagon on insulin‐induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
Diabetes Obesity and Metabolism.
18.
2016
Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
The Lancet Diabetes & Endocrinology.
4.
2016
Evidence of Extrapancreatic Glucagon Secretion in Man.
Diabetes.
65.
2016
Feedback suppression of meal‐induced glucagon‐like peptide‐1 (GLP‐1) secretion mediated through elevations in intact GLP‐1 caused by dipeptidyl peptidase‐4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment.
Diabetes Obesity and Metabolism.
18.
2016
GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes.
Diabetes Care.
39.
2016
Glucagon-like Peptide 1 Receptor Signaling in Acinar Cells Causes Growth-Dependent Release of Pancreatic Enzymes.
Cell Reports.
17.
2016
Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy.
AJP Endocrinology and Metabolism.
310.
2016
Glucose-Dependent Insulinotropic Polypeptide Is Associated With Lower Low-Density Lipoprotein But Unhealthy Fat Distribution, Independent of Insulin: The ADDITION-PRO Study.
The Journal of Clinical Endocrinology & Metabolism.
101.
2016
Gut hormones and gastric bypass.
Cardiovascular Endocrinology & Metabolism.
5.
2016
Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose Infusion..
The Journal of Clinical Endocrinology & Metabolism.
101.
2016
IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test.
Journal of Diabetes Science and Technology.
10.
2016
Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia.
Endocrine Connections.
5.
2016
In vivo and in vitro degradation of peptide YY3–36 to inactive peptide YY3–34 in humans.
AJP Regulatory Integrative and Comparative Physiology.
310.
2016
Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion.
Journal of Diabetes Research.
2016.
2016
Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans..
The Journal of Clinical Endocrinology & Metabolism.
101.
2016
Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation.
Diabetes.
65.
2016
Integrative Genomics Outlines a Biphasic Glucose Response and a ChREBP-RORγ Axis Regulating Proliferation in β Cells.
Cell Reports.
16.
2016
Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial..
American Journal of Clinical Nutrition.
103.
2016
Liraglutide for treating type 1 diabetes.
Expert Opinion on Biological Therapy.
16.
2016
Major rapid weight loss induces changes in cardiac repolarization.
Journal of Electrocardiology.
49.
2016
Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor.
Surgery for Obesity and Related Diseases.
12.
2016
Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
PLoS ONE.
11.
2016
Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism.
Endocrinology.
157.
2016
No Islet Cell Hyperfunction, but Altered Gut-Islet Regulation and Postprandial Hypoglycemia in Glucose-Tolerant Patients 3 Years After Gastric Bypass Surgery.
Obesity Surgery.
26.
2016
N‐terminally and C‐terminally truncated forms of glucose‐dependent insulinotropic polypeptide are high‐affinity competitive antagonists of the human GIP receptor.
British Journal of Pharmacology.
173.
2016
Oral 2‐oleyl glyceryl ether improves glucose tolerance in mice through the GPR119 receptor.
BioFactors.
42.
2016
Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma.
EBioMedicine.
7.
2016
Pancreatic polypeptide responses to isoglycemic oral and intravenous glucose in humans with and without intact vagal innervation.
Neuropeptides.
55.
2016
Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation.
Endocrinology Diabetes and Metabolism Case Reports.
2016.
2016
Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
International Journal of Obesity.
40.
2016
Peptide YY3-36 and glucagon-like peptide-1 in functional dyspepsia. Secretion and role in symptom generation.
Scandinavian Journal of Gastroenterology.
51.
2016
Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells.
Journal of Molecular Endocrinology.
56.
2016
Proteomics reveals the effects of sustained weight loss on the human plasma proteome.
Molecular Systems Biology.
12.
2016
Quantification of the Contribution of GLP-1 to Mediating Insulinotropic Effects of DPP-4 Inhibition With Vildagliptin in Healthy Subjects and Patients With Type 2 Diabetes Using Exendin [9-39] as a GLP-1 Receptor Antagonist.
Diabetes.
65.
2016
Rapid gut growth but persistent delay in digestive function in the postnatal period of preterm pigs.
AJP Gastrointestinal and Liver Physiology.
310.
2016
Regulation of Pancreatic α-Cell Function and Proliferation by Bone Morphogenetic Protein 4 (BMP4) In Vitro..
Endocrinology.
157.
2016
Regulation of gut hormone secretion. Studies using isolated perfused intestines.
Peptides.
77.
2016
Roles of the Gut in Glucose Homeostasis.
Diabetes Care.
39.
2016
Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota.
Genome Medicine.
8.
2016
Searching for the physiological role of glucose‐dependent insulinotropic polypeptide.
Journal of Diabetes Investigation.
7.
2016
Serum lipase activity and concentration during intravenous infusions of GLP‐1 and PYY3‐36 and after ad libitum meal ingestion in overweight men.
Physiological Reports.
4.
2016
Short‐term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial.
Diabetes Obesity and Metabolism.
18.
2016
Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors.
British Journal of Pharmacology.
173.
2016
Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3–36.
European Journal of Endocrinology.
174.
2016
Surgical or medical therapy for patients with obesity and T2DM?.
Nature Reviews Endocrinology.
12.
2016
The anorexic hormone Peptide YY3-36 is rapidly metabolized to inactive Peptide YY3-34 in vivo.
Neuropeptides.
55.
2016
The biology of glucagon and the consequences of hyperglucagonemia.
Biomarkers in Medicine.
10.
2016
The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss.
Nutrition & Diabetes.
6.
2016
The insulinotropic effect of exogenous glucagon‐like peptide‐1 is not affected by acute vagotomy in anaesthetized pigs.
Experimental Physiology.
101.
2016
The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs.
BMC Research Notes.
9.
2016
The regulation of function, growth and survival of GLP-1-producing L-cells..
Clinical Science.
130.
2016
Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets.
Diabetologia.
59.
2016
Use of anesthesia dramatically alters the oral glucose tolerance and insulin secretion in C57Bl/6 mice.
Physiological Reports.
4.
2016
Weight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levels.
Metabolomics.
12.
2016
Accelerated protein digestion and amino acid absorption after Roux-en-Y gastric bypass.
American Journal of Clinical Nutrition.
102.
2015
Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow.
American Journal of Physiology. Renal physiology.
308.
2015
An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine..
Endocrinology.
156.
2015
Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein–Coupled Bile Acid Receptors.
Endocrinology.
156.
2015
Bile acid mediated effects on gut integrity and performance of early-weaned piglets.
BMC Veterinary Research.
11.
2015
Central 5-HT Neurotransmission Modulates Weight Loss following Gastric Bypass Surgery in Obese Individuals.
Journal of Neuroscience.
35.
2015
Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients.
Nephrology,Dialysis and Transplantation.
30.
2015
Dairy proteins, dairy lipids, and postprandial lipemia in persons with abdominal obesity (DairyHealth): a 12-wk, randomized, parallel-controlled, double-blinded, diet intervention study.
American Journal of Clinical Nutrition.
101.
2015
Difference in Postprandial GLP‐1 Response Despite Similar Glucose Kinetics after Consumption of Wheat Breads with Different Particle Size in Healthy Men.
The FASEB Journal.
29.
2015
Differential effects of glucagon‐like peptide‐1 on microvascular recruitment and glucose metabolism in short‐ and long‐term insulin resistance.
The Journal of Physiology.
593.
2015
Dual‐hormone treatment with insulin and glucagon in patients with type 1 diabetes.
Diabetes/Metabolism Research and Reviews.
31.
2015
Early gradual feeding with bovine colostrum improves gut function and NEC resistance relative to infant formula in preterm pigs.
AJP Gastrointestinal and Liver Physiology.
309.
2015
Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients.
Journal of Diabetes and its Complications.
29.
2015
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism.
PLoS ONE.
10.
2015
Effect of Moderate- and High-Intensity Acute Exercise on Appetite in Obese Individuals.
Medicine & Science in Sports & Exercise.
47.
2015
Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
The Journal of Clinical Endocrinology & Metabolism.
100.
2015
Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
Diabetologia.
58.
2015
Effects of acute exercise on pancreatic endocrine function in subjects with type 2 diabetes.
Diabetes Obesity and Metabolism.
17.
2015
Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes.
Journal of the Renin-Angiotensin-Aldosterone System.
16.
2015
Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes.
International Journal of Obesity.
39.
2015
Effects of sitagliptin on counter‐regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double‐blind placebo‐controlled crossover study.
Diabetes Obesity and Metabolism.
17.
2015
Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study.
BMJ Open.
5.
2015
Elongation of the small intestine in case of experimentally induced exocrine pancreatic insufficiency in young pigs – is GLP 2 the trigger?.
Pancreatology.
15.
2015
Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes.
Diabetologia.
58.
2015
Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® shows modest effect on triacylglycerol in young healthy adults..
Beneficial Microbes.
6.
2015
GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women..
The Journal of Clinical Endocrinology & Metabolism.
100.
2015
GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study.
Diabetes.
64.
2015
GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass.
Endocrinology Diabetes and Metabolism Case Reports.
2015.
2015
GLP1- and GIP-producing cells rarely overlap and differ by bombesin receptor-2 expression and responsiveness.
Journal of Endocrinology.
228.
2015
Gastric bypass surgery has a weight-loss independent effect on post-challenge serum glucose levels.
Diabetology & Metabolic Syndrome.
7.
2015
Gastric emptying and disease activity in inflammatory bowel disease.
European Journal of Clinical Investigation.
45.
2015
Glucose stimulates neurotensin secretion from the rat small intestine by mechanisms involving SGLT1 and GLUT2, leading to cell depolarization and calcium influx.
AJP Endocrinology and Metabolism.
308.
2015
Glucose-Dependent Insulinotropic Polypeptide Augments Glucagon Responses to Hypoglycemia in Type 1 Diabetes.
Diabetes.
64.
2015
Heterogeneity of glucagonomas due to differential processing of proglucagon-derived peptides.
Endocrinology Diabetes and Metabolism Case Reports.
2015.
2015
Hypoglycemia-Associated Changes in the Electroencephalogram in Patients With Type 1 Diabetes and Normal Hypoglycemia Awareness or Unawareness.
Diabetes.
64.
2015
Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.
AJP Endocrinology and Metabolism.
308.
2015
Impaired incretin effect is an early sign of glucose dysmetabolism in nondiabetic patients with psoriasis.
Journal of Internal Medicine.
278.
2015
Important species differences regarding lymph contribution to gut hormone responses.
Peptides.
71.
2015
Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations..
The Journal of Clinical Endocrinology & Metabolism.
100.
2015
Inability to match energy intake with energy expenditure at sustained near-maximal rates of energy expenditure in older men during a 14-d cycling expedition..
American Journal of Clinical Nutrition.
102.
2015
Incretin and glucagon levels in adult offspring exposed to maternal diabetes in pregnancy..
The Journal of Clinical Endocrinology & Metabolism.
100.
2015
Incretin effect after oral amino acid ingestion in humans..
The Journal of Clinical Endocrinology & Metabolism.
100.
2015
Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis.
Journal of Gastroenterology and Hepatology.
30.
2015
Infrared thermographic assessment of changes in skin temperature during hypoglycaemia in patients with type 1 diabetes.
Diabetologia.
58.
2015
Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose-Tolerant Humans: A Proof of Concept.
Diabetes Care.
38.
2015
Liraglutide for Type 2 diabetes and obesity: a 2015 update.
Expert Review of Cardiovascular Therapy.
13.
2015
Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide.
Journal of Diabetes and its Complications.
29.
2015
Molecular Mechanisms of Glucose-Stimulated GLP-1 Secretion From Perfused Rat Small Intestine.
Diabetes.
64.
2015
Pancreatic polypeptide responses to isoglycemic oral and intravenous glucose in humans with and without intact vagal innervation.
Peptides.
71.
2015
Patients with psoriasis are insulin resistant.
Journal of the American Academy of Dermatology.
72.
2015
Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young.
European Journal of Endocrinology.
173.
2015
Preoperative β‐cell function in patients with type 2 diabetes is important for the outcome of Roux‐en‐Y gastric bypass surgery.
The Journal of Physiology.
593.
2015
Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance.
Diabetologia.
58.
2015
Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men.
AJP Endocrinology and Metabolism.
308.
2015
Resistant starch and protein intake enhances fat oxidation and feelings of fullness in lean and overweight/obese women.
Nutrition Journal.
14.
2015
Response to Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513–2525.
Diabetes.
64.
2015
Restoration of the insulinotropic effect of glucose‐dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase‐4 inhibitors.
Diabetes Obesity and Metabolism.
17.
2015
Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial.
Diabetes Care.
39.
2015
Sensing of triacylglycerol in the gut: different mechanisms for fatty acids and 2‐monoacylglycerol.
The Journal of Physiology.
593.
2015
Specific inhibition of bile acid transport alters plasma lipids and GLP-1.
BMC Cardiovascular Disorders.
15.
2015
Stability of glucagon-like peptide 1 and glucagon in human plasma.
Endocrine Connections.
4.
2015
The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans.
American Journal of Clinical Nutrition.
102.
2015
The Use of Gastrostomy Tube for the Long-Term Remission of Hyperinsulinemic Hypoglycemia After Roux-en-y Gastric Bypass: A Case Report.
AACE Clinical Case Reports.
1.
2015
The VGF-Derived Neuropeptide TLQP-21 Shows No Impact on Hormone Secretion in the Isolated Perfused Rat Pancreas..
Hormone and Metabolic Research.
47.
2015
The anorexic hormone Peptide YY3–36 is rapidly metabolized to inactive Peptide YY3–34 in vivo.
Physiological Reports.
3.
2015
The effects of TNF-α on GLP-1-stimulated plasma glucose kinetics..
The Journal of Clinical Endocrinology & Metabolism.
100.
2015
The glucagon-like peptide 2 receptor is expressed in enteric neurons and not in the epithelium of the intestine.
Peptides.
67.
2015
The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes.
Diabetologia.
58.
2015
The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1.
AJP Regulatory Integrative and Comparative Physiology.
309.
2015
The structure of wheat bread influences the postprandial metabolic response in healthy men.
Food & Function.
6.
2015
Transcriptional and Functional Characterization of the G Protein-Coupled Receptor Repertoire of Gastric Somatostatin Cells.
Endocrinology.
156.
2015
Transfer of liraglutide from blood to cerebrospinal fluid is minimal in patients with type 2 diabetes.
International Journal of Obesity.
39.
2015
Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss.
International Journal of Obesity.
39.
2015
Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
Diabetes Care.
38.
2015
Type 2 diabetes mellitus.
Nature Reviews Disease Primers.
1.
2015
Updates in weight loss surgery and gastrointestinal peptides.
Current Opinion in Endocrinology Diabetes and Obesity.
22.
2015
Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP‐1 secretion from isolated perfused rat small intestine.
Physiological Reports.
3.
2015
l-Glutamine and Whole Protein Restore First-Phase Insulin Response and Increase Glucagon-Like Peptide-1 in Type 2 Diabetes Patients.
Nutrients.
7.
2015
A 25-Year-Old Woman with Type 2 Diabetes and Liver Disease.
Case Reports in Gastroenterology.
8.
2014
A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture Risk.
The Journal of Clinical Endocrinology & Metabolism.
99.
2014
Acute effects of monounsaturated fat on postprandial lipemia and gene expression in first-degree relatives of subjects with type 2 diabetes.
European Journal of Clinical Nutrition.
68.
2014
Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.
BMJ Open.
4.
2014
Consumption of a Diet Low in Advanced Glycation End Products for 4 Weeks Improves Insulin Sensitivity in Overweight Women.
Diabetes Care.
37.
2014
Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade.
Diabetes.
63.
2014
Direct effect of glucagon‐like peptide‐1 on the autoregulatory response of the afferent arteriole (692.2).
The FASEB Journal.
28.
2014
Distal Gastrectomy in Pancreaticoduodenectomy is Associated with Accelerated Gastric Emptying, Enhanced Postprandial Release of GLP-1, and Improved Insulin Sensitivity.
Journal of Gastrointestinal Surgery.
18.
2014
Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial.
BMJ Open.
4.
2014
Dose response of continuous subcutaneous infusion of recombinant glucagon‐like peptide‐1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus.
Diabetes Obesity and Metabolism.
16.
2014
Early Enhancements of Hepatic and Later of Peripheral Insulin Sensitivity Combined With Increased Postprandial Insulin Secretion Contribute to Improved Glycemic Control After Roux-en-Y Gastric Bypass.
Diabetes.
63.
2014
Effect of IL-6 on the insulin sensitivity in patients with type 2 diabetes.
AJP Endocrinology and Metabolism.
306.
2014
Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals.
European Journal of Nutrition.
53.
2014
Effects of PYY3–36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men.
AJP Endocrinology and Metabolism.
306.
2014
Effects of Sitagliptin and Metformin Treatment on Incretin Hormone and Insulin Secretory Responses to Oral and “Isoglycemic” Intravenous Glucose.
Diabetes.
63.
2014
Effects of chronic glucagon-like peptide-2 therapy during weaning in neonatal pigs.
Peptides.
188.
2014
Effects of concentrated arabinoxylan and β-glucan compared with refined wheat and whole grain rye on glucose and appetite in subjects with the metabolic syndrome: a randomized study.
European Journal of Clinical Nutrition.
68.
2014
Effects of hydrolysed casein, intact casein and intact whey protein on energy expenditure and appetite regulation: a randomised, controlled, cross-over study.
British Journal Of Nutrition.
112.
2014
Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease..
The Journal of Clinical Endocrinology & Metabolism.
99.
2014
Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans.
AJP Gastrointestinal and Liver Physiology.
306.
2014
GLP-1 Responses Are Heritable and Blunted in Acquired Obesity With High Liver Fat and Insulin Resistance.
Diabetes Care.
37.
2014
GLP-1 amidation efficiency along the length of the intestine in mice, rats and pigs and in GLP-1 secreting cell lines.
Peptides.
55.
2014
GLP-1 as a Mediator in the Remission of Type 2 Diabetes After Gastric Bypass and Sleeve Gastrectomy Surgery.
Diabetes.
63.
2014
GLP-1 increases microvascular recruitment but not glucose uptake in human and rat skeletal muscle.
AJP Endocrinology and Metabolism.
306.
2014
Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals.
Diabetologia.
57.
2014
Glucagon-like peptide 2 treatment may improve intestinal adaptation during weaning.
Journal of Animal Science.
92.
2014
Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males.
Endocrine Connections.
3.
2014
Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients..
The Journal of Clinical Psychiatry.
75.
2014
Glucose-Lowering Effects and Low Risk of Hypoglycemia in Patients With Maturity-Onset Diabetes of the Young When Treated With a GLP-1 Receptor Agonist: A Double-Blind, Randomized, Crossover Trial.
Diabetes Care.
37.
2014
Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients With Type 2 Diabetes.
The Journal of Clinical Endocrinology & Metabolism.
99.
2014
Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects.
International Journal of Obesity.
38.
2014
Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans..
The Journal of Clinical Endocrinology & Metabolism.
99.
2014
Glutamate prevents intestinal atrophy via luminal nutrient sensing in a mouse model of total parenteral nutrition.
The FASEB Journal.
28.
2014
Glycemic Effects and Safety of L-Glutamine Supplementation with or without Sitagliptin in Type 2 Diabetes Patients—A Randomized Study.
PLoS ONE.
9.
2014
High saturated fatty acid intake induces insulin secretion by elevating gastric inhibitory polypeptide levels in healthy individuals.
Nutrition Research.
34.
2014
Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?.
Diabetologia.
57.
2014
Impact of the Reconstruction Method on Delayed Gastric Emptying After Pylorus-Preserving Pancreaticoduodenectomy: A Prospective Randomized Study.
World Journal of Surgery.
38.
2014
Incretin Effect and Glucagon Responses to Oral and Intravenous Glucose in Patients With Maturity-Onset Diabetes of the Young—Type 2 and Type 3.
Diabetes.
63.
2014
Influence of GLP-1 on Myocardial Glucose Metabolism in Healthy Men during Normo- or Hypoglycemia.
PLoS ONE.
9.
2014
Insulin Resistance Alters Islet Morphology in Nondiabetic Humans.
Diabetes.
63.
2014
KCNQ1 Long QT Syndrome Patients Have Hyperinsulinemia and Symptomatic Hypoglycemia.
Diabetes.
63.
2014
Lactobacillus paracasei subsp paracasei L. casei W8 suppresses energy intake acutely.
Appetite.
82.
2014
Mechanisms behind the superior effects of interval vs continuous training on glycaemic control in individuals with type 2 diabetes: a randomised controlled trial.
Diabetologia.
57.
2014
Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery.
The Lancet Diabetes & Endocrinology.
2.
2014
Normal physical activity obliterates the deleterious effects of a high-caloric intake.
Journal of Applied Physiology.
116.
2014
On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes.
Endocrine Connections.
3.
2014
PS-188 Intestino-trophic Effects Of Minimal Enteral Nutrition In Preterm And Term Piglets.
Archives of Disease in Childhood.
99.
2014
Postprandial effects of test meals including concentrated arabinoxylan and whole grain rye in subjects with the metabolic syndrome: a randomised study.
European Journal of Clinical Nutrition.
68.
2014
Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
European Journal of Endocrinology.
171.
2014
Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
Nephrology,Dialysis and Transplantation.
29.
2014
Similar weight‐adjusted insulin secretion and insulin sensitivity in short‐duration late autoimmune diabetes of adulthood (LADA) and Type 2 diabetes: Action LADA 8.
Diabetic Medicine.
31.
2014
Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans.
European Journal of Endocrinology.
170.
2014
Specificity and sensitivity of commercially available assays for glucagon‐like peptide‐1 (GLP‐1): implications for GLP‐1 measurements in clinical studies.
Diabetes Obesity and Metabolism.
16.
2014
Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model.
AJP Gastrointestinal and Liver Physiology.
307.
2014
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment.
Expert Review of Endocrinology & Metabolism.
9.
2014
The Authors Reply:.
Kidney International.
85.
2014
The Melanocortin-4 Receptor Is Expressed in Enteroendocrine L Cells and Regulates the Release of Peptide YY and Glucagon-like Peptide 1 In Vivo.
Cell Metabolism.
20.
2014
The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects.
European Journal of Endocrinology.
171.
2014
The incretin effect does not differ in trained and untrained, young, healthy men.
Acta Physiologica.
210.
2014
The interleukin‐1 receptor antagonist anakinra improves first‐phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance.
Diabetes Obesity and Metabolism.
16.
2014
The use of double-balloon enteroscopy in retrieving mucosal biopsies from the entire human gastrointestinal tract.
Scandinavian Journal of Gastroenterology.
49.
2014
Therapies for inter-relating diabetes and obesity – GLP-1 and obesity.
Expert Opinion on Pharmacotherapy.
15.
2014
Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report.
BMC Research Notes.
7.
2014
-
chapter
-
Treatment with GLP-1 Receptor Agonists.
Springer Nature.
2018
Afferent Endocrine Control of Eating.
Wiley.
2016
Incretin hormones as a target for therapy.
Springer Nature.
2016
-
dataset
-
Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice.
public-library-of-science.
2018
Incretin responses to oral glucose and mixed meal tests and changes in fasting glucose levels during 7 years of follow-up: The Hoorn Meal Study.
public-library-of-science.
2018
Population characteristics at baseline (n = 121)..
public-library-of-science.
2018
Regression coefficients (with 95% confidence intervals) for the association of the iAUC of GIP and GLP-1 following OGTT and MMT at baseline and change in fasting plasma glucose levels during 7.0 years of follow-up..
public-library-of-science.
2018
Regression coefficients (with 95% confidence intervals) for the association of the tAUC of GIP and GLP-1 following OGTT and MMT at baseline and change in fasting plasma glucose levels during 7.0 years of follow-up..
public-library-of-science.
2018
Table_1_Glucose Tolerance Tests and Osteocalcin Responses in Healthy People.DOCX.
frontiers.
2018
Bowel morphology and crypt cell proliferation..
public-library-of-science.
2017
Clinical characteristics of the study population..
public-library-of-science.
2017
DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity.
public-library-of-science.
2017
Significance of main effects and interactions of resection with GLP-2 on all endpoints depicted in figures..
public-library-of-science.
2017
Target and endogenous control gene primer sequences and annealing temperatures for qPCR..
public-library-of-science.
2017
A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats.
public-library-of-science.
2016
Additional file 2: of Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota.
springer-nature.
2016
Biochemical blood analyses and hemograms before and after 12 weeks of treatment with either exenatide or placebo..
public-library-of-science.
2016
Hormone, glucose and body composition analyses before and after 12 weeks of either exenatide or placebo treatment..
public-library-of-science.
2016
MOESM1 of The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs.
springer-nature.
2016
Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
public-library-of-science.
2016
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism.
public-library-of-science.
2015
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism - Table 1.
public-library-of-science.
2015
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism - Table 2.
public-library-of-science.
2015
Effects of the treatments on full blood count, renal and liver function and plasma electrolytes..
public-library-of-science.
2014
Effects of the treatments on glycemic markers, weight and blood pressure..
public-library-of-science.
2014
Glycemic Effects and Safety of L-Glutamine Supplementation with or without Sitagliptin in Type 2 Diabetes Patients—A Randomized Study.
public-library-of-science.
2014
Influence of GLP-1 on Myocardial Glucose Metabolism in Healthy Men during Normo- or Hypoglycemia.
public-library-of-science.
2014
-
hide from search
-
Baseline characteristics..
public-library-of-science.
2013
Cognitive function, EEG and symptoms of hypoglycemia during experiments..
public-library-of-science.
2013
Counter-regulatory hormones..
public-library-of-science.
2013
Influence of Erythropoietin on Cognitive Performance during Experimental Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Randomized Cross-Over Trial.
public-library-of-science.
2013
Metabolic and β-cell function parameters (mean±SE or median [interquartile range])*..
public-library-of-science.
2013
Statistical significance of differences by test, dose, and group (ANOVA for doubly repeated measures)*..
public-library-of-science.
2013
A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients.
Peptides.
2013
Acute differential effects of dietary protein quality on postprandial lipemia in obese non-diabetic subjects.
Nutrition Research.
2013
Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study.
Peptides.
2013
Appetite regulation in overweight, sedentary men after different amounts of endurance exercise: a randomized controlled trial.
Journal of Applied Physiology.
2013
Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty.
European Journal of Endocrinology.
2013
Contribution of gastroenteropancreatic appetite hormones to protein-induced satiety.
American Journal of Clinical Nutrition.
2013
Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol.
BMC Cardiovascular Disorders.
2013
Early growth and postprandial appetite regulatory hormone responses.
British Journal Of Nutrition.
2013
Effects of a meal rich in medium-chain saturated fat on postprandial lipemia in relatives of type 2 diabetics.
Nutrition.
2013
Effects of oleic acid and olive oil on gastric emptying, gut hormone secretion and appetite in lean and overweight or obese males.
Clinical Nutrition ESPEN.
2013
Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes.
Diabetes.
2013
Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
Diabetologia.
2013
Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux‐en‐Y gastric bypass.
Neurogastroenterology & Motility.
2013
GLP-2 Delays but Does Not Prevent the Onset of Necrotizing Enterocolitis in Preterm Pigs.
Journal of Pediatric Gastroenterology and Nutrition.
2013
Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease.
Kidney International.
2013
Glucagon-Like Peptide-1 (GLP-1): Effect on Kidney Hemodynamics and Renin-Angiotensin-Aldosterone System in Healthy Men.
The Journal of Clinical Endocrinology & Metabolism.
2013
Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain.
Frontiers in Neuroenergetics.
2013
Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.
AJP Gastrointestinal and Liver Physiology.
2013
Glucose metabolism is altered after loss of L cells and α-cells but not influenced by loss of K cells.
AJP Endocrinology and Metabolism.
2013
Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
International Journal of Obesity.
2013
Increased expression of glucagon‐like peptide‐1 receptors in psoriasis plaques.
Experimental Dermatology.
2013
Increased hepatic insulin clearance after Roux-en-Y gastric bypass..
The Journal of Clinical Endocrinology & Metabolism.
2013
Incretin and pancreatic hormone secretion in Caucasian non‐diabetic carriers of the TCF7L2 rs7903146 risk T allele.
Diabetes Obesity and Metabolism.
2013
Influence of Erythropoietin on Cognitive Performance during Experimental Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Randomized Cross-Over Trial.
PLoS ONE.
2013
Is there a place for incretin therapies in obesity and prediabetes?.
Trends in Endocrinology and Metabolism.
2013
Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?.
Metabolism.
2013
Metformin protects against lipoapoptosis and enhances GLP-1 secretion from GLP-1-producing cells.
Journal of Gastroenterology.
2013
Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.
AJP Gastrointestinal and Liver Physiology.
2013
Reduced postprandial GLP‐1 responses in women with gestational diabetes mellitus.
Diabetes Obesity and Metabolism.
2013
Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: A case report.
Obesity Research & Clinical Practice.
2013
Regulation of urea synthesis during the acute-phase response in rats.
AJP Gastrointestinal and Liver Physiology.
2013
Removal of Duodenum Elicits GLP-1 Secretion.
Diabetes Care.
2013
Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study.
BMJ Open.
2013
Secretion of Glucose-Dependent Insulinotropic Polypeptide in Patients With Type 2 Diabetes.
Diabetes Care.
2013
Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.
Diabetologia.
2013
The C-terminal extension of exendin-4 provides additional metabolic stability when added to GLP-1, while there is minimal effect of truncating exendin-4 in anaesthetized pigs.
Peptides.
2013
The CTRB1/2 Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway.
Diabetes.
2013
The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial.
BMJ Open.
2013
The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty.
AJP Gastrointestinal and Liver Physiology.
2013
The l-α-amino acid receptor GPRC6A is expressed in the islets of Langerhans but is not involved in l-arginine-induced insulin release.
Amino Acids.
2013
Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.
Diabetic Medicine.
2013
Tumour necrosis factor‐alpha infusion produced insulin resistance but no change in the incretin effect in healthy volunteers.
Diabetes/Metabolism Research and Reviews.
2013
Content of amino acids in the whey and soy protein isolates..
public-library-of-science.
2012
Early postprandial incremental areas under the curve (iAUC) for plasma glucose and serum insulin responses1..
public-library-of-science.
2012
Effects of Pre-Meal Drinks with Protein and Amino Acids on Glycemic and Metabolic Responses at a Subsequent Composite Meal.
public-library-of-science.
2012
Incremental postprandial areas under the curve (iAUC 0–60 min) for the different plasma amino acids1..
public-library-of-science.
2012
Plasma glucose and serum insulin responses after the meals1..
public-library-of-science.
2012
Serving sizes and nutritional compositions of the reference and test meals1..
public-library-of-science.
2012
Spearman’s partial correlation coefficients and P values controlling for subjects and corresponding baseline values (two-tailed test), for the relations between plasma amino acids, plasma incretins, serum insulin (iAUC 0–15 min, respectively), and plasma glucose (expressed as GI, GP and Glucose iPeak)1..
public-library-of-science.
2012
Association between measures of metabolic traits and the rs6232 G-allele and the rs6235 C-allele of PCSK1 among 6,039 treatment-naïve Danes..
public-library-of-science.
2011
Association between measures of obesity stratified according to sex for the PCSK1 rs6235 among 5,788 treatment-naïve Danes..
public-library-of-science.
2011
Interaction analyses for rs6232 and rs6235 of PCSK1 with sex, age and glucose tolerance status for metabolic traits..
public-library-of-science.
2011
PCSK1 rs6235 stratified measures of metabolic traits among 4,393 glucose tolerant individuals (NGT) and 1,395 Danes with impaired glucose regulation..
public-library-of-science.
2011
The Effect of PCSK1 Variants on Waist, Waist-Hip Ratio and Glucose Metabolism Is Modified by Sex and Glucose Tolerance Status.
public-library-of-science.
2011
-
patent
-
COMBINATION THERAPY FOR TREATMENT OF BONE DISORDERS
2019
GIP PEPTIDE ANALOGUES
2019
GIP PEPTIDE ANALOGUES
2019
PEPTIDE DUAL AGONISTS OF GIPR AND GLP2R
2019
PEPTIDE DUAL AGONISTS OF GIPR AND GLP2R
2019
GIP PEPTIDE ANALOGUES
2018
GIP PEPTIDE ANALOGUES
2018
LONG-ACTING GIP PEPTIDE ANALOGUES
2018
LONG-ACTING GIP PEPTIDE ANALOGUES
2018
PEPTIDE DUAL AGONISTS OF GIPR AND GLP2R
2018
GIP PEPTIDE ANALOGUES
2017
GIP PEPTIDE ANALOGUES
2016